CWVGX
Price
$20.83
Change
-$0.55 (-2.57%)
Updated
Apr 7 closing price
Net Assets
901.35M
RERHX
Price
$49.00
Change
-$1.35 (-2.68%)
Updated
Apr 7 closing price
Net Assets
114.24B
Ad is loading...

CWVGX vs RERHX

Header iconCWVGX vs RERHX Comparison
Open Charts CWVGX vs RERHXBanner chart's image
Calvert International Equity A
Price$20.83
Change-$0.55 (-2.57%)
VolumeN/A
Net Assets901.35M
American Funds Europacific Growth R5E
Price$49.00
Change-$1.35 (-2.68%)
VolumeN/A
Net Assets114.24B
CWVGX vs RERHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWVGX vs. RERHX commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWVGX is a Hold and RERHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERHX has more cash in the bank: 114B vs. CWVGX (901M). RERHX pays higher dividends than CWVGX: RERHX (1.35) vs CWVGX (1.13). CWVGX was incepted earlier than RERHX: CWVGX (33 years) vs RERHX (9 years). CWVGX (1.20) is less costly to investors than RERHX (0.62). RERHX is a more actively managed with annual turnover of: 30.00 vs. CWVGX (23.00). RERHX has a lower initial minimum investment than CWVGX: RERHX (250) vs CWVGX (1000). CWVGX annual gain was more profitable for investors over the last year : -6.56 vs. RERHX (-14.51). CWVGX return over 5 years is better than : 29.28 vs. RERHX (16.82).
CWVGXRERHXCWVGX / RERHX
Total Expense Ratio1.140.62184%
Annual Report Gross Expense Ratio1.200.62194%
Fund Existence33 years9 years-
Gain YTD-6.002-7.98175%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets901M114B1%
Annual Yield % from dividends1.131.3584%
Returns for 1 year-6.56-14.5145%
Returns for 3 years-2.91-8.9233%
Returns for 5 years29.2816.82174%
Returns for 10 years33.03N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIO229.403.80
+1.68%
Bio-Rad Laboratories IncClass A
EBF19.06-0.34
-1.75%
Ennis
FCPT26.80-0.89
-3.21%
Four Corners Property Trust
LCTX0.40-0.03
-7.45%
Lineage Cell Therapeutics
GLMD1.24-0.10
-7.46%
Galmed Pharmaceuticals Ltd